Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry.

Autor: Wern Yew Ding, Lane, Deirdre A., Gupta, Dhiraj, Huisman, Menno V., Lip, Gregory Y. H., Ding, Wern Yew, GLORIA‐AF Investigators
Zdroj: Journal of the American Heart Association; 8/2/2022, Vol. 11 Issue 15, p1-24, 24p
Databáze: Complementary Index
Externí odkaz: